The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Seminars in Medicine of the Beth Israel Deaconess Medical Center
PreviousPrevious
Volume 328:1828-1835 June 24, 1993 Number 25
NextNext

The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Scott L. Friedman

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Hepatic fibrosis is a common response to chronic liver injury from many causes, including alcohol, persistent viral and helminthic infections, and hereditary metal overload. Emerging evidence suggests that cellular mechanisms of hepatic fibrosis are shared among these different insults and, moreover, that the liver's response is a paradigm for parenchymal wound healing in other tissues.

Advances in the isolation and characterization of liver cells, in conjunction with progress in matrix and cytokine biology, have led to important new insights about the cellular basis of hepatic fibrosis. In particular, the hepatic lipocyte (also known as the stellate, fat-storing, perisinusoidal, or Ito . . . [Full Text of this Article]

The Nature of the Hepatic Scar

Cellular Sources of Extracellular Matrix in Hepatic Fibrosis: The Role of the Activated Lipocyte

Lipocytes: The Main Source of Extracellular Matrix in Liver Injury

Lipocyte Activation: The Critical Event in Early Hepatic Fibrosis

Initiation of Lipocyte Activation

Perpetuation of Lipocyte Activation

Therapies for Hepatic Fibrosis

Current Therapies

Future Therapies

Conclusions

Discussion


Source Information

From the Department of Medicine, University of California, San Francisco, and the Medical Service, San Francisco General Hospital, San Francisco.

Address reprint requests to Dr. Friedman at UCSF Liver Center Laboratory, San Francisco General Hospital, Bldg. 40, Rm. 4102, San Francisco, CA 94110.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.